View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - DaunoDouble - Daunorubicin 60 / Cytarabine 100, AML Induction I+II, under 60 years of age
Protocol-ID: 627 V1.1 (Mini), STUDY-DAUNODOUBLE- DAUN60/CYTA100, AML Ind. I+II under 60 yrsStudy protocol, available to authorized participants only.
Indication(s)
- Acute Myeloid Leukemia; ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.04.2021